000 03377nam a2200433 i 4500
999 _c9940
_d9940
001 9940
003 ES-VaUE
005 20210525174009.0
006 m o d |
007 cr nn 008mamaa
008 210311s2021 sz a o 001 0 eng d
020 _a3030548597
024 7 _a10.1007/978-3-030-54859-9
_2doi
040 _aMiAaPQ
_beng
_erda
_epn
_cMiAaPQ
_dMiAaPQ
050 _aRL321
_b.W45 2021 EB
072 7 _aMJK
_2bicssc
072 7 _aMED017000
_2bisacsh
072 7 _aMJK
_2thema
082 0 _a616.526
_223
245 0 0 _aAdvances in psoriasis :
_ba multisystemic guide
_cJeffrey M. Weinberg, Mark Lebwohl
250 _a2nd ed. 2021
264 1 _aCham, Switzerland
_bSpringer
_c2021
300 _a1 online resource (VI, 423 p. 54 illus., 45 illus. in color.)
336 _atext
_btxt [
_2rdacontent]
337 _acomputer
_bc [
_2rdamedia]
338 _aonline resource
_bcr [
_2rdacarrier]
500 _aIncludes index
505 0 _aIntroduction to and History of Psoriasis and Psoriasis Therapy -- Pathophysiology of Psoriasis/Novel Pathways -- Psoriasis: Clinical Review and Update -- Psoriasis: Epidemiology, Potential Triggers, Disease Course -- Topical Therapy I: Corticosteroids and Vitamin D Analogues -- Topical Therapy II: Retinoids, Immunomodulators, and Others -- Topical Therapy II: Retinoids, Immunomuodulators, and Others/ Ultraviolet Therapy for Psoriasis -- Laser Therapy for Psoriasis -- Traditional Systemic Therapy I: Methotrexate and Cyclosporine -- Traditional Systemic Therapy II: Retinoids and Others -- Apremilast -- Etanercept -- Adalimumab -- Infliximab, Golimumab , and Certolizumab Pegol -- Ustekinumab -- Guselkumab -- Tidrakizumab -- Risankizumab -- Secukinumab -- Ixekizumab -- Brodalumab -- Biosimilars for Psoriasis -- Research Pipeline I: Oral Therapeutics for Psoriasis -- Research Pipeline II: Upcoming Biologic Therapies -- Pediatric Psoriasis -- Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement -- Psoriasis and Comorbidities -- Summary of Published Treatment Guidelines -- Index
520 _aThis extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease. Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients
650 0 _aPsoriasis-
_xTreatment
650 0 _aPsoriasis
655 4 _aElectronic books
700 1 _aLebwohl, Mark,
_eeditor
700 1 _aWeinberg, Jeffrey M.,
_eeditor
776 _z3-030-54858-9
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-54859-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db